July 26, 2019 (Arlington, Virginia) — This morning CASE Chairman Gerard Scimeca issued a statement praising the Department of Justice’s […]
President Trump’s approach toward trade negotiations from day one has emphasized one theme above all others; the “bad deals” made […]
(Arlington, Virginia) — CASE launches new ad imploring the Senate to abandon a proposal that would place inflationary price caps […]
July 19, 2019 We recently learned that the White House is asking Senate Democrats to include two proposals in […]
July 19, 2019 Statement by Gerard Scimeca, Vice President, Consumer Action for a Strong Economy (CASE), in response to announcement […]
Matthew Kandrach – President, CASE July 16,2019 It’s time — past due time — to bury nuclear power. A […]
Gerard Scimeca – Chairman, CASE July 16, 2019 https://bit.ly/2JB88Fc In an era when electric vehicles (EVs) are shaking up […]
Gerard Scimeca – Chairman, CASE July 15, 2019 https://bit.ly/2XO2ymF President Trump schooled Democrats once again last month with the announcement […]
July 15, 2019 CASE wishes to thank Chairman Pai and the FCC for their efforts to affirm the legal limits […]
July 11, 2019 Back in January of this year millions cheered President Trump’s plan to finally hold pharmacy benefit managers […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/